Rani Therapeutics, LLC Wed, Jun 21, 2023, 8:00 AM4 min read ...

Announced strategic research collaboration with Chugai for two undisclosed molecules – – Presented preclinical data ...

The data will be presented today, May 8, 2024, from 3:00 p.m. – 3:15 p.m. ET at ASGCT in an oral presentation entitled “Development of an In Vivo Non-Viral Ocular Editing Platform and ...

Presentation Details: Title: "Use of lucicebtide (ST101) in glioblastoma patients by antagonism of C/EBPβ-dependent mesenchymal cell transition and immunosuppressive M2 macrophage polarization" ...

The data will be presented in an oral session at the Muscular Dystrophy Association (MDA) 2025 Clinical and Scientific Conference taking place on March 16-19 in Dallas, Texas.

Provided by PR NewswireJun 1, 2025, 1:39:00 AM ASCO 2025 Oral Presentation: Innovent Biologics Announces Updated Data of IBI363 (First-in-class PD-1/IL-2α -bias Bispecific Antibody Fusion Protein ...